1. Home
  2. ENTA vs PTLO Comparison

ENTA vs PTLO Comparison

Compare ENTA & PTLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTA
  • PTLO
  • Stock Information
  • Founded
  • ENTA 1995
  • PTLO 1963
  • Country
  • ENTA United States
  • PTLO United States
  • Employees
  • ENTA N/A
  • PTLO N/A
  • Industry
  • ENTA Biotechnology: Pharmaceutical Preparations
  • PTLO Restaurants
  • Sector
  • ENTA Health Care
  • PTLO Consumer Discretionary
  • Exchange
  • ENTA Nasdaq
  • PTLO Nasdaq
  • Market Cap
  • ENTA 316.2M
  • PTLO 344.6M
  • IPO Year
  • ENTA 2013
  • PTLO 2021
  • Fundamental
  • Price
  • ENTA $12.65
  • PTLO $5.09
  • Analyst Decision
  • ENTA Strong Buy
  • PTLO Buy
  • Analyst Count
  • ENTA 6
  • PTLO 9
  • Target Price
  • ENTA $20.33
  • PTLO $9.89
  • AVG Volume (30 Days)
  • ENTA 387.8K
  • PTLO 3.0M
  • Earning Date
  • ENTA 11-17-2025
  • PTLO 11-04-2025
  • Dividend Yield
  • ENTA N/A
  • PTLO N/A
  • EPS Growth
  • ENTA N/A
  • PTLO N/A
  • EPS
  • ENTA N/A
  • PTLO 0.35
  • Revenue
  • ENTA $65,324,000.00
  • PTLO $730,930,000.00
  • Revenue This Year
  • ENTA $2.13
  • PTLO $5.70
  • Revenue Next Year
  • ENTA $2.74
  • PTLO $8.18
  • P/E Ratio
  • ENTA N/A
  • PTLO $14.42
  • Revenue Growth
  • ENTA N/A
  • PTLO 2.40
  • 52 Week Low
  • ENTA $4.09
  • PTLO $4.58
  • 52 Week High
  • ENTA $15.34
  • PTLO $15.78
  • Technical
  • Relative Strength Index (RSI)
  • ENTA 66.08
  • PTLO 44.82
  • Support Level
  • ENTA $11.89
  • PTLO $4.58
  • Resistance Level
  • ENTA $13.00
  • PTLO $4.82
  • Average True Range (ATR)
  • ENTA 0.83
  • PTLO 0.22
  • MACD
  • ENTA 0.09
  • PTLO 0.08
  • Stochastic Oscillator
  • ENTA 80.78
  • PTLO 61.94

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

About PTLO Portillo's Inc.

Portillos Inc serves the Chicago street food industry through high-energy and multichannel restaurants designed to ignite the senses and create memorable dining experiences. It owns and operates fast-casual restaurants in the United States, along with two food production commissaries in Illinois. Its menu includes hot dogs, beef and sausage sandwiches, sandwiches and ribs, salads, burgers, chicken, Barnelli's pasta, sides and soup, and desserts and shakes.

Share on Social Networks: